Gyre Therapeutics
GYRE
#6266
Rank
$0.63 B
Marketcap
$6.80
Share price
-4.09%
Change (1 day)
-60.37%
Change (1 year)

P/S ratio for Gyre Therapeutics (GYRE)

P/S ratio as of April 2025 (TTM): 6.02

According to Gyre Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.47. At the end of 2024 the company had a P/S ratio of 10.1.

P/S ratio history for Gyre Therapeutics from 2024 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202410.1